Evolving molecular mechanism-based strategies for control of hepatocellular carcinoma.

Sato, K; Mori, M

Sato, K; Mori, M.

Affiliation

Sato K; Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan. satoken@showa.gunma-u.ac.jp

Curr Med Chem ; 18(28): 4375-88, 2011.

Article in En | MEDLINE | ID: mdl-21861817

Subject(s)

Antineoplastic Agents/therapeutic use; Carcinoma, Hepatocellular/drug therapy; Antineoplastic Agents/metabolism; Antineoplastic Agents/pharmacology; Carcinoma, Hepatocellular/metabolism; Carcinoma, Hepatocellular/mortality; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Liver Neoplasms/drug therapy; Liver Neoplasms/metabolism; Liver Neoplasms/mortality; Receptors, Growth Factor/antagonists & inhibitors; Receptors, Growth Factor/metabolism; Signal Transduction/drug effects

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Antineoplastic Agents Type of study: Clinical_trials / Prognostic_studies Language: En Journal: Curr Med Chem Year: 2011 Type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links